EMN EASTMAN CHEMICAL CO

EMN financial statements, revenue, balance sheet, cash flow, and SEC filings

CIK: 915389 Exchange: NYSE SIC: 2821 (Plastic Materials, Synth Resins & Nonvulcan Elastomers) Latest filing: 10-Q filed Jul 31, 2026 Data checked: Oct 21, 2026
Showing 3 of 18 annual and 0 of 72 quarterly periods. Full history available with a free account or via API.

▼ Company Profile

Filer Category
Large accelerated filer
Entity Type
Operating
Public Float
$8.45B (Dec 2025)
Industry (SIC)
2821 Plastic Materials, Synth Resins & Nonvulcan Elastomers
Incorporated
DE
Fiscal Year End
December (1231)
Phone
4232292000
EIN
621539359
Headquarters
KINGSPORT, TN, 37660
Public Float History
Market value of shares held by public investors, reported in annual DEI filings.

▼ Key Metrics (TTM)

As of Jun 30, 2026
Financials
Revenue
$8.87B
Net Income
$442.00M
Total Assets
$15.42B
Total Equity
$6.18B
Total Debt
$5.22B
Free Cash Flow
$539.00M
Ratios
Gross Margin
19.9%
Net Margin
5%
Return on Equity
7.2%
Return on Assets
2.9%
Current Ratio
1.5x
Debt / Equity
0.84x
FCF / Assets
3.5%

▼ FY 2025 Summary Analysis

Annual report ending Dec 31, 2025

Overview and Growth

EASTMAN CHEMICAL CO generated $8.75B of revenue in fiscal 2025, with net income of $474.00M and an operating cash inflow of $970.00M. At $8.75B, the top line establishes the operating scale supporting the company’s profit and cash-flow profile. Revenue was 6.7% below fiscal 2024 revenue of $9.38B, marking a top-line contraction. On a per-share basis, diluted EPS was $4.10, which connects the reported earnings outcome with the company’s diluted share count. Diluted EPS decreased by 46.5% from $7.67 in fiscal 2024, showing how the earnings change reached shareholders on a per-share basis. Revenue equaled 0.59x of total assets, indicating how much reported top-line activity the company produced relative to its period-end asset base.

Profitability

Gross profit was $1.84B, representing the portion of revenue remaining after the reported cost of revenue and before operating expenses. Gross profit represented 21.1% of revenue, showing how much of the top line remained after direct costs. Net income came to $474.00M, completing the progression from revenue through gross and operating profitability to the final reported result. Net margin was 5.4%, meaning that this portion of revenue remained as net income after all recognized expenses. Before income taxes, the company reported $568.00M of earnings, providing a bridge between the operating result and final net income. The pretax margin was 6.5%, relating income before taxes directly to revenue. Income tax expense totaled $93.00M, providing the reported tax component that separates pretax and after-tax earnings. The income-tax provision equaled 16.4% of pretax income, showing the tax burden absorbed by the year’s earnings.

Liquidity and Capital Structure

The company held $14.86B of assets against $8.82B of liabilities and $6.04B of equity, revealing how the asset base was financed. Current assets were $3.65B against $2.65B of current liabilities, framing the resources and obligations classified within the near-term balance-sheet horizon. The current ratio was 1.37x, with current assets exceeding current liabilities and providing a short-term liquidity cushion. Reported cash and equivalents were $566.00M, separating immediately recognizable cash resources from the rest of the current-asset base. Measured only with cash and equivalents, coverage of current liabilities was 21.3%, excluding receivables and other current assets. Total debt was $4.79B, establishing the amount of borrowing carried within the company’s capital structure. The debt-to-equity relationship was 0.79x, showing how much debt the company carried for each unit of book equity. Relative to total assets, debt measured 32.2%, showing how much of the asset base was matched by borrowing. The liabilities-to-assets relationship was 59.4%, placing reported obligations against the full positive asset balance. Cash and equivalents equaled 3.8% of total assets, showing the liquid cash component within the company’s broader resource base. The asset base changed 2.3% from $15.21B in fiscal 2024, leaving current total assets lower year over year.

Cash Flow and Earnings Quality

Cash flow from operations was $970.00M, a reported cash inflow that can be compared directly with net income and capital spending. Against net income, operating cash flow measured 2.05x, showing the relationship between accrual earnings and operating cash. Capital spending was $546.00M, absorbing part of the cash generated from operations before free cash flow. Capital spending absorbed 56.3% of operating cash flow, quantifying the share of cash from operations directed to investment. The combination of operating cash flow and capital spending produced $424.00M of positive free cash flow for the period. The free-cash-flow margin was 4.8%, measuring cash remaining after capital spending against revenue. Free cash flow equaled 2.9% of total assets, relating post-investment cash generation to the company’s resource base.
Based on the annual report for the fiscal year ending Dec 31, 2025. Analysis generated .
Sources and calculation details

Reported values are preserved. Derived values use the listed inputs; unavailable inputs remain blank.

Field-level sources for this historical record are unavailable until it is rebuilt from SEC facts.

Annual financial statements for EASTMAN CHEMICAL CO
Metric FY2025 📄 FY2024 📄 FY2023 📄
Income Statement
REVENUE
Revenue $8.75B $9.38B $9.21B
Cost of Revenue $6.91B $7.09B $7.15B
Gross Profit $1.84B $2.29B $2.06B
OPERATING EXPENSES
R&D Expense $255.00M $250.00M $239.00M
SG&A Expense $658.00M $736.00M $727.00M
NON-OPERATING INCOME / EXPENSE
Other Income/Expense $-74.00M $-36.00M $-37.00M
Pretax Income $568.00M $1.08B $1.09B
Income Tax $93.00M $170.00M $191.00M
Net Income $474.00M $905.00M $894.00M
PER SHARE & SUPPLEMENTAL
Diluted EPS $4.10 $7.67 $7.49
Diluted Shares 115.60M 117.90M 119.40M
Depreciation & Amortization $513.00M $509.00M $498.00M
Balance Sheet
ASSETS
Cash & Equivalents $566.00M $837.00M $548.00M
Accounts Receivable $737.00M $791.00M $826.00M
Inventory $1.98B $1.99B $1.68B
Other Current Assets $100.00M $104.00M $96.00M
Current Assets $3.65B $4.10B $3.48B
PP&E (Net) $5.73B $5.62B $5.55B
Goodwill $3.67B $3.63B $3.65B
Intangible Assets $970.00M $1.03B $1.14B
Other Noncurrent Assets $848.00M $833.00M $820.00M
Noncurrent Assets $11.21B $11.11B $11.15B
Total Assets $14.86B $15.21B $14.63B
LIABILITIES
Accounts Payable $2.07B $2.26B $2.04B
Short-term Debt $586.00M $450.00M $541.00M
Other Current Liabilities (derived) $0 $0 $0
Current Liabilities $2.65B $2.71B $2.58B
Long-term Debt $4.20B $4.57B $4.31B
Other Noncurrent Liabilities $891.00M $923.00M $954.00M
Noncurrent Liabilities $6.17B $6.65B $6.53B
Total Liabilities $8.82B $9.36B $9.10B
EQUITY
Common Stock $2.00M $2.00M $2.00M
Additional Paid-in Capital $2.50B $2.46B $2.37B
Retained Earnings $10.11B $10.01B $9.49B
Accumulated OCI $-160.00M $-314.00M $-319.00M
Total Equity $6.04B $5.85B $5.53B
Total Liabilities & Equity $14.86B $15.21B $14.63B
SUPPLEMENTAL
Total Debt $4.79B $5.02B $4.85B
Shares Outstanding 114.10M 115.17M 117.34M
Check: A − (L + E + Temp. Equity) - - -
Cash Flow Statement
Cash from Operations $970.00M $1.29B $1.37B
Capital Expenditures $546.00M $599.00M $828.00M
Cash from Investing $-462.00M $-534.00M $-432.00M
Cash from Financing $-797.00M $-454.00M $-888.00M
Free Cash Flow $424.00M $688.00M $546.00M
Beginning Cash (CFS) $837.00M $548.00M $493.00M
Net Change in Cash $-289.00M $299.00M $54.00M
Effect of FX on Cash $18.00M $-10.00M $1.00M
Calculated Ending Cash $566.00M $837.00M $548.00M
Cash per BS $566.00M $837.00M $548.00M
Cash scope difference (CFS − BS) - - -
Cash per CFS $566.00M $837.00M $548.00M

Create a free account to see full history, quarterly data, charts, CSV downloads, and API access.

Create Free Account Log In
🔒

Quarterly data and charts require a free account

Get access to 8 quarters of data, interactive charts, CSV downloads, and API access.

▼ Frequently Asked Questions

What is EASTMAN CHEMICAL CO's annual revenue?

EASTMAN CHEMICAL CO reported $8.87B in revenue for trailing twelve months (ending June 2026). Revenue figures are sourced from the company's annual SEC EDGAR filing.

Is EASTMAN CHEMICAL CO profitable?

Yes. EASTMAN CHEMICAL CO reported $442.00M in net income for trailing twelve months. Profitability data is based on the company's most recent annual report filed with the SEC.

What is EASTMAN CHEMICAL CO's debt level?

EASTMAN CHEMICAL CO carries $5.22B in total debt as of trailing twelve months. Total shareholders' equity stands at $6.18B.

Does EASTMAN CHEMICAL CO generate free cash flow?

Yes. Free cash flow was $539.00M for trailing twelve months. Operating cash flow was $991.00M.